Search

In Stock

Buy Rinvoq (upadacitinib) Online

Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

$1,955.31

Clear
Compare

Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Here is a detailed description of Rinvoq:

Active Ingredient:

  • Upadacitinib: Upadacitinib is a selective Janus kinase 1 (JAK1) inhibitor. It works by specifically inhibiting the activity of JAK1, which is involved in the signaling pathways responsible for inflammation. By doing so, upadacitinib helps to reduce inflammation and mitigate the symptoms of autoimmune diseases.

Indications:

Rinvoq is indicated for the treatment of the following medical conditions:

  1. Rheumatoid Arthritis (RA): Rinvoq is used to treat moderate to severe rheumatoid arthritis in adult patients who have not responded well to other disease-modifying antirheumatic drugs (DMARDs).
  2. Psoriatic Arthritis: It is also used for the treatment of psoriatic arthritis, an inflammatory joint condition that occurs in some individuals with psoriasis.
  3. Ankylosing Spondylitis: Rinvoq is indicated for the treatment of ankylosing spondylitis, a chronic inflammatory disease that primarily affects the spine.

Usage:

The dosing and administration of Rinvoq are determined by a healthcare provider and depend on the specific condition being treated. It is typically taken orally in the form of tablets, usually once daily.

Mechanism of Action:

Upadacitinib, the active ingredient in Rinvoq, works by selectively inhibiting JAK1, a critical enzyme in the inflammatory signaling pathways. By targeting JAK1, upadacitinib interferes with the inflammatory response, helping to reduce pain, swelling, and joint damage in autoimmune diseases.

Benefits:

Rinvoq offers the benefit of effectively managing autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It can help reduce inflammation, alleviate joint pain, and improve overall quality of life for patients.

Precautions:

Before starting Rinvoq, patients should undergo a thorough evaluation by a healthcare provider. It is important to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication.

Side Effects:

Common side effects of Rinvoq may include upper respiratory tract infections, headache, and increased liver enzyme levels. Patients may also be at a slightly increased risk of infections while taking Rinvoq. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Rinvoq (upadacitinib) is a medication used to treat autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by selectively inhibiting JAK1, a key enzyme involved in the inflammatory process. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

30 extended-release tablets of 15 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Tymlos (abaloparatide) Online

$2,636.72
(0 Reviews)
DISEASE INDICATIONS: Osteoporosis MANUFACTURER: Radius Health, Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Buy Truxima (rituximab) Online

From $623.55
(0 Reviews)
DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medsafe (NZ) Truxima (rituximab) is a drug employed in the management of various medical conditions, including follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

Buy Jyseleca (filgotinib) Online

From $1,239.61
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Galapagos USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA)   Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

Back to Top
Product has been added to your cart